LRLucía Gutiérrez Romero

Lucía Gutiérrez Romero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucía Gutiérrez Romero has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mass Spectrometric Platforms to Study Cisplatin Resistance in Cell Models and Alternative Nano-Delivery Systems

    by Maria Montes-Bayón, Lucía Romero, Carlos López-Portugués, Paula Díez, Mario Corte-Rodriguez

    The positive chemotherapeutic effect of cisplatin in most cancers (e.g. ovarian, prostate, etc.) is hampered by the inherent and acquired drug resistance, a multifactorial and still not well characterized process. Several mechanisms have been suggested to participate in conferring platinum-resistant properties to a tumor cell that need to be carefully studied in order to provide therapeutic alternatives. In this Letter, two different aspects are addressed: 1) the evaluation of molecular mechanisms involved in cisplatin resistance by the use of combined multi-strategy platforms based on mass spectrometry, and 2) the search for therapeutic alternatives to enhance efficacy and selectivity of cisplatin based on the use of nanotransporters. Both approaches are briefly discussed from the point of view of the analytical chemistry contribution.

  • Open Access

    Single cell combined with laser ablation ICP-MS to study cisplatinum (IV) loaded nanoparticles penetration pathways in osteosarcoma spheroids

    by L. Gutierrez-Romero, B. Gallego, E. Blanco, U. Karst, R. Rodríguez, M. Montes-Bayon


  • Open Access

    Capabilities of Single Cell ICP-MS for the Analysis of Cell Suspensions from Solid Tissues

    by Roberto Álvarez-Fernández García, Lucía Gutiérrez Romero, Jörg Bettmer, Maria Montes-Bayón

    Single cell elemental (SC) analysis of isogenic cell cultures can be done using inductively coupled plasma (ICP-MS) detection. However, 2D cell cultures are just models to simplify the complexity of real tissue samples. Here, we show for the first time the capabilities of the technique (SC-ICP-MS) to analyze single cell suspensions of isolated cells from tissues. An optimized cocktail of proteolytic and collagenolytic enzymes was applied in a single preparation step with cellular yields up to 28% using 0.5 g of fresh rat spleen and liver, respectively. The retrieved cells revealed adequate morphology and stability to be examined by SC-ICP-MS. Quantitative elemental analysis of P, S, Cu, and Fe from disaggregated cells from rat spleen and liver tissues revealed levels of Fe of 7–16 fg/cell in the spleen and 8–12 fg/cell in the liver, while Cu was about 3–5 fg/cell in the spleen and 1.5–2.5 fg/cell in the liver. Evaluation of the transmembrane protein transferrin receptor 1 (TfR1) expression levels in disaggregated cells was also conducted by using a Nd-labelled antibody against this cell surface biomarker. Quantitative results showed significantly lower expression in the disaggregated cells than in the cell model HepG2, in agreement with the overexpression of this biomarker in tumor cells. In this proof of concept study, the tissue disaggregation protocol has shown to maintain the elemental intracellular content of cells as well as the presence of relevant antigens. This opens a completely new area of research for SC-ICP-MS in tissue samples as a complementary strategy with validation capabilities.


  • Open Access

    Intracellular Biotransformation of Ultrasmall Iron Oxide Nanoparticles and Their Effect in Cultured Human Cells and in Drosophila Larvae In Vivo

    by Alonso Rodríguez Pescador, Lucía Gutiérrez Romero, Elisa Blanco-González, María Montes-Bayón, L. María Sierra

    A systematic investigation on the cellular uptake, intracellular dissolution, and in vitro biological effects of ultra-small (Drosophila melanogaster, using the eye-SMART test. The obtained results showed that FeAT-NPs were genotoxic only with the two highest tested concentrations (2 and 5 mmol·L−1 of Fe) in surface treatments. These data altogether show that these nanoparticles represent a safe alternative for anemia management, with high uptake level and controlled iron release.


  • Open Access

    Cellular Toxicity Mechanisms and the Role of Autophagy in Pt(IV) Prodrug-Loaded Ultrasmall Iron Oxide Nanoparticles Used for Enhanced Drug Delivery

    by L. Gutiérrez-Romero, L. Rivas-García, C. Sánchez-González, J. Llopis, E. Blanco, M. Montes-Bayón

    Ultrasmall iron oxide nanoparticles (<10 nm) were loaded with cis-diamminetetrachloroplatinum (IV), a cisplatin (II) prodrug, and used as an efficient nanodelivery system in cell models. To gain further insight into their behavior in ovarian cancer cells, the level of cellular incorporation as well as the platination of mitochondrial and nuclear DNA were measured using inductively coupled plasma mass spectrometry (ICP-MS) strategies. Quantitative Pt results revealed that after 24 h exposure to 20 µM Pt in the form of the Pt(IV)-loaded nanoparticles, approximately 10% of the incorporated Pt was associated with nuclear DNA. This concentration increased up to 60% when cells were left to stand in drug-free media for 3 h. These results indicated that the intracellular reducing conditions permitted the slow release of cisplatin (II) from the cisplatin (IV)-loaded nanoparticles. Similar results were obtained for the platination of mitochondrial DNA, which reached levels up to 17,400 ± 75 ng Pt/ mg DNA when cells were left in drug-free media for 3 h, proving that this organelle was also a target for the action of the released cisplatin (II). The time-dependent formation of Pt-DNA adducts could be correlated with the time-dependent decrease in cell viability. Such a decrease in cell viability was correlated with the induction of apoptosis as the main route of cell death. The formation of autophagosomes, although observed upon exposure in treated cells, does not seem to have played an important role as a means for cells to overcome nanoparticles’ toxicity. Thus, the designed nanosystem demonstrated high cellular penetration and the “in situ” production of the intracellularly active cisplatin (II), which is able to induce cell death, in a sustained manner.